Clinical Trial Update: Selinexor in Combination With Thalidomide and Dexamethasone in RRMM [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating selinexor in combination with thalidomide and dexamethasone for relapsed/refractory multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Selinexor (selinexor)
• Thalidomide (thalidomide)

Snippet

Sponsor: Li Zheng | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN